Collectively, our results demonstrate that the non-metabolic activity of 6PGD regulates ALKBH5 and promotes global m6A modification in CRC, adding another dimension to the regulation of CRC tumor growth and metastasis through the MDM2-CCNA2/HMGA2 axis in a non-metabolic manner. The gene discussed is ALKBH5; the disease is neoplasm.